- Consumer Products
- Latest 1.82
- Currency C$
- Change 0.0000
- Percent Change 0.00 %
- Volume 0
- Fri Sep 5, 2014 02:29 PM EDT TSX data delayed 15 minutes.
12 months ended Apr 30, 2014.
Trailing 12 month results shown above.
All data is in Canadian dollars.
|Earnings||Jun 17||n/a||Nov 4||n/a|
12 months ended Sep 17, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
HELIX BIOPHARMA CORP. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing products for the prevention and treatment of cancer. Helix's product development initiatives include Topical Interferon Alpha-2b and its new drug candidate L-DOS47 .